Author
Listed:
- A. S. Widge
(Massachusetts General Hospital and Harvard Medical School
Massachusetts Institute of Technology
University of Minnesota)
- S. Zorowitz
(Massachusetts General Hospital and Harvard Medical School
Princeton Neuroscience Institute)
- I. Basu
(Massachusetts General Hospital and Harvard Medical School)
- A. C. Paulk
(Massachusetts General Hospital and Harvard Medical School)
- S. S. Cash
(Massachusetts General Hospital and Harvard Medical School)
- E. N. Eskandar
(Massachusetts General Hospital and Harvard Medical School
Albert Einstein College of Medicine—Montefiore Medical Center)
- T. Deckersbach
(Massachusetts General Hospital and Harvard Medical School)
- E. K. Miller
(Massachusetts Institute of Technology)
- D. D. Dougherty
(Massachusetts General Hospital and Harvard Medical School)
Abstract
Deep brain stimulation (DBS) is a circuit-oriented treatment for mental disorders. Unfortunately, even well-conducted psychiatric DBS clinical trials have yielded inconsistent symptom relief, in part because DBS’ mechanism(s) of action are unclear. One clue to those mechanisms may lie in the efficacy of ventral internal capsule/ventral striatum (VCVS) DBS in both major depression (MDD) and obsessive-compulsive disorder (OCD). MDD and OCD both involve deficits in cognitive control. Cognitive control depends on prefrontal cortex (PFC) regions that project into the VCVS. Here, we show that VCVS DBS’ effect is explained in part by enhancement of PFC-driven cognitive control. DBS improves human subjects’ performance on a cognitive control task and increases theta (5–8Hz) oscillations in both medial and lateral PFC. The theta increase predicts subjects’ clinical outcomes. Our results suggest a possible mechanistic approach to DBS therapy, based on tuning stimulation to optimize these neurophysiologic phenomena.
Suggested Citation
A. S. Widge & S. Zorowitz & I. Basu & A. C. Paulk & S. S. Cash & E. N. Eskandar & T. Deckersbach & E. K. Miller & D. D. Dougherty, 2019.
"Deep brain stimulation of the internal capsule enhances human cognitive control and prefrontal cortex function,"
Nature Communications, Nature, vol. 10(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09557-4
DOI: 10.1038/s41467-019-09557-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09557-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.